Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UTRN | P46939 | 5/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | AHR | P35869 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PTPN2 | P17706 | 3/20 | 0.40 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.40 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.40 |
| ▸ | HSPD1 | P10809 | 2/20 | 0.40 |
| ▸ | HSPE1 | P61604 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | SLC47A1 | Q96FL8 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29431588 | 1.00 | UTRN (0.43) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL17231828 | 0.91 | UTRN (0.43) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL25315137 | 0.88 | UTRN (0.43) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL30989624 | 0.88 | UTRN (0.43) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL15858547 | 0.86 | LMNA (0.33) | MAPTMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL29431630 | 0.86 | LMNA (0.33) | MAPTMEN1KMT2ASMN1; SMN2LMNA | |
| SCHEMBL20607634 | 0.86 | UTRN (0.40) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL17609284 | 0.86 | UTRN (0.40) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL21525988 | 0.85 | UTRN (0.41) | UTRNCYP1A2AHRHDAC6MAPT | |
| SCHEMBL17231823 | 0.85 | UTRN (0.39) | UTRNCYP1A2AHRHDAC6MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112021322-B | Compositions and methods for controlling pests | 住友化学株式会社 | 2022-04-01 | — | — | CN | disclosed |
| CN-112021322-A | Compositions and methods for controlling pests | 住友化学株式会社 | 2020-12-04 | — | — | CN | disclosed |
| EP-2952099-B1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | SUMITOMO CHEMICAL CO (JP) | 2018-10-17 | — | — | EP | disclosed |
| EP-2952100-B1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | SUMITOMO CHEMICAL CO (JP) | 2018-10-10 | — | — | EP | disclosed |
| EP-2952097-B1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | SUMITOMO CHEMICAL CO (JP) | 2018-10-10 | — | — | EP | disclosed |
| US-9974307-B2 | Composition and method for controlling pests | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-22 | — | — | US | disclosed |
| US-9974307-B2 | Composition and method for controlling pests | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-05-22 | — | — | US | disclosed |
| EP-2938601-B1 | FUSED OXAZOLE COMPOUNDS AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL CO (JP) | 2018-05-16 | — | — | EP | disclosed |
| EP-2938601-B1 | FUSED OXAZOLE COMPOUNDS AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL CO (JP) | 2018-05-16 | — | — | EP | disclosed |
| US-9883675-B2 | Method for controlling pests | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-02-06 | — | — | US | disclosed |
| US-20150359223-A1 | COMPOSITION AND METHOD FOR CONTROLLING PESTS | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-12-17 | — | — | US | disclosed |
| EP-2952098-A1 | PEST-CONTROL METHOD | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952097-A1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952099-A1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| EP-2952100-A1 | PEST-CONTROL COMPOSITION AND PEST-CONTROL METHOD | Sumitomo Chemical Company, Limited (JP) | 2015-12-09 | — | — | EP | disclosed |
| US-20150313234-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-05 | — | — | US | disclosed |
| US-20150313234-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-11-05 | — | — | US | disclosed |
| EP-2938601-A1 | FUSED OXAZOLE COMPOUNDS AND USE THEREOF FOR PEST CONTROL | Sumitomo Chemical Company Limited (JP) | 2015-11-04 | — | — | EP | disclosed |
| WO-2014104407-A1 | FUSED OXAZOLE COMPOUNDS AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-03 | — | — | WO | disclosed |
| WO-2014104407-A1 | FUSED OXAZOLE COMPOUNDS AND USE THEREOF FOR PEST CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150313234-A1 | FUSED HETEROCYCLIC COMPOUND AND USE THEREOF FOR PEST CONTROL | AFF1, AFF2, PYM1 | UTRN 4827/4885CYP1A2 105/4885AHR 145/4885 |
| US-20150359223-A1 | COMPOSITION AND METHOD FOR CONTROLLING PESTS | PNPO, NAMPT, NNT | UTRN 4825/4885CYP1A2 217/4885AHR 1221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.